Chrysonthia joined atai Life Sciences in 2021. Previously, Chrysonthia was an investment banker at Goldman Sachs, where she worked on capital markets transactions and M&A for technology, media, and telecom companies.
Chrysonthia started her career as a financial analyst at Goldin Associates (now a Teneo company), a boutique restructuring and distressed situations firm.
Chrysonthia holds a Bachelor’s degree in Biology and Brain & Cognitive Sciences from MIT and a J.D. from Harvard Law School.